Ilsung Pharm Capital Reinvestment Ratio
Ilsung Pharm capital reinvestment ratio. Ilsung Pharm (003120) has a Capital Reinvestment Ratio of 5.88x as of June 2026, meaning it reinvests 6% of its operating cash flow (₩124.28 Million) in capital expenditures (₩731.07 Million). Check total reinvestment intensity of Ilsung Pharm to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ilsung Pharm (2013–2025)
Capital reinvestment ratio of Ilsung Pharm from 2013 to 2025. This chart tracks Ilsung Pharm's Capital Reinvestment Ratio across 9 annual periods. Also explore net asset momentum of Ilsung Pharm to track the company's year-over-year net asset growth rate.
Ilsung Pharm Capital Reinvestment Ratio by Year (2013–2025)
Ilsung Pharm capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see Ilsung Pharm cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | ₩3.88 Billion | ₩2.18 Billion | ▼ -70.7% |
| 2021 | 1.92x | ₩5.70 Billion | ₩10.93 Billion | ▼ -38.1% |
| 2020 | 3.09x | ₩1.56 Billion | ₩4.82 Billion | ▲ +994.5% |
| 2019 | 0.28x | ₩4.39 Billion | ₩1.24 Billion | ▲ +252.7% |
| 2018 | 0.08x | ₩15.09 Billion | ₩1.21 Billion | ▼ -56.0% |
| 2017 | 0.18x | ₩10.16 Billion | ₩1.85 Billion | ▼ -61.4% |
| 2015 | 0.47x | ₩6.04 Billion | ₩2.85 Billion | ▲ +109.0% |
| 2014 | 0.23x | ₩4.19 Billion | ₩945.31 Million | ▲ +1.4% |
| 2013 | 0.22x | ₩5.06 Billion | ₩1.13 Billion | — |